Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 12,000 | 220,000 | 37,000 | 1,885,000 | -494,000 |
| Other Working Capital | 2,563,000 | -636,000 | -262,000 | -177,000 | 1,356,000 |
| Other Operating Activity | -1,074,000 | 897,000 | 442,000 | -1,338,000 | 1,348,000 |
| Operating Cash Flow | $1,501,000 | $481,000 | $217,000 | $370,000 | $2,210,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -506,000 | -317,000 | -254,000 | -231,000 | -399,000 |
| Net Acquisitions | -48,000 | 234,000 | -69,000 | 7,411,000 | 100,000 |
| Purchase Sale Intangibles | 92,000 | -112,000 | -145,000 | -120,000 | -98,000 |
| Other Investing Activity | 273,000 | 23,000 | 12,000 | 30,000 | 92,000 |
| Investing Cash Flow | $-425,000 | $-172,000 | $-456,000 | $7,090,000 | $-379,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -5,000 | -1,118,000 | -644,000 | -645,000 | -2,417,000 |
| Debt Issued | N/A | N/A | N/A | N/A | 1,960,000 |
| Common Stock Issued | 36,000 | 4,000 | 5,000 | 28,000 | 43,000 |
| Common Stock Repurchased | -6,000 | -15,000 | -15,000 | -63,000 | -5,000 |
| Dividend Paid | -888,000 | -951,000 | -1,111,000 | -924,000 | -918,000 |
| Other Financing Activity | -103,000 | 65,000 | -575,000 | -178,000 | -326,000 |
| Financing Cash Flow | $-966,000 | $-2,015,000 | $-2,340,000 | $-1,782,000 | $-1,663,000 |
| Exchange Rate Effect | -50,000 | 26,000 | -149,000 | 128,000 | 61,000 |
| Beginning Cash Position | 5,426,000 | 7,106,000 | 9,834,000 | 4,028,000 | 3,799,000 |
| End Cash Position | 5,486,000 | 5,426,000 | 7,106,000 | 9,834,000 | 4,028,000 |
| Net Cash Flow | $110,000 | $-1,706,000 | $-2,579,000 | $5,678,000 | $168,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,501,000 | 481,000 | 217,000 | 370,000 | 2,210,000 |
| Capital Expenditure | -678,000 | -443,000 | -415,000 | -365,000 | -586,000 |
| Free Cash Flow | 823,000 | 38,000 | -198,000 | 5,000 | 1,624,000 |